Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Non-beta-amyloid/tau cerebrospinal fluid markers inform staging and progression in Alzheimer’s disease

Abstract Background Alzheimer’s disease (AD) is a complex neurodegenerative disorder characterized by neuropathologic changes involving beta-amyloid (Aβ), tau, neuronal loss, and other associated biological events. While levels of cerebrospinal fluid (CSF) Aβ and tau peptides have enhanced the antem...

Full description

Bibliographic Details
Main Authors: Umesh Gangishetti, J. Christina Howell, Richard J. Perrin, Natalia Louneva, Kelly D. Watts, Alexander Kollhoff, Murray Grossman, David A. Wolk, Leslie M. Shaw, John C. Morris, John Q. Trojanowski, Anne M. Fagan, Steven E. Arnold, William T. Hu
Format: Article
Language:English
Published: BMC 2018-09-01
Series:Alzheimer’s Research & Therapy
Subjects:
Biomarkers
Fatty acid binding protein
Interleukin-10
Mild cognitive impairment
Neurofilament light chain
Online Access:http://link.springer.com/article/10.1186/s13195-018-0426-3

Internet

http://link.springer.com/article/10.1186/s13195-018-0426-3

Similar Items